Although patients with comorbidities were excluded in order to avoid their effect on NLRP2 rs9239 and vaspin rs6242 SNP genotype analysis, the most important limitation of our study was the inability to ensure BMI homogeneity between the OSA and control groups. This evidence concerns the gene SERPINA12 and obstructive sleep apnea syndrome.